Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma
Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma
R. Overman,Tanvi T. Kartal,23 Authors,E. Newman
2020 · DOI: 10.1002/pbc.28153
Pediatric Blood & Cancer · 25 Citations
TLDR
The objective of this study is to determine whether PCNB is adequate for modern biologic characterization of neuroblastoma.
Abstract
Image‐guided percutaneous core needle biopsy (PCNB) is increasingly utilized to diagnose solid tumors. The objective of this study is to determine whether PCNB is adequate for modern biologic characterization of neuroblastoma.